← FDA DRUG APPROVALS

FDA ANDA · ANDA070992

DROPERIDOL

Sponsor: ABRAXIS PHARM

APPLICATION
ANDA070992
TYPE
ANDA
ORIGINAL APPROVAL
1986-11-17
LATEST ACTION
1992-09-23
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DROPERIDOLDiscontinued
DROPERIDOL 2.5MG/ML · INJECTABLE · INJECTION

Approval history

1992-09-23Labeling · Supplement 3AP
1992-05-27Labeling · Supplement 10AP
1988-09-22Labeling · Supplement 4AP
1986-11-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →